Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone calls may boost chemo success in leukemia patients

NCT ID NCT01393366

First seen Apr 05, 2026 · Last updated Jun 23, 2026 · Updated 9 times

Summary

This study tested whether weekly nurse phone calls could help people with chronic lymphocytic leukemia (CLL) stick to their chemotherapy plan and reduce side effects. Sixty patients were split into two groups: one received regular care, and the other also got a weekly call to check on their health. The goal was to see if the calls helped patients get the full planned dose of their chemo drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CH Saint Jean

    Perpignan, 66046, France

  • CHU Purpan

    Toulouse, 31059, France

  • Centre Hospitalier de la côte basque

    Bayonne, 64109, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Telephone intervention (nurse phone calls)

What this could lead to

If it works, this could show that simple phone support helps patients complete chemotherapy with fewer dose reductions and side effects.

What could go wrong

This is a small, early study with only 60 people. The phone calls may not make a meaningful difference, and results may not apply to other treatments or hospitals.

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.